Expression of PTEN, PPM1A and P-Smad2 in hepatocellular carcinomas and adjacent liver tissues

World Journal of Gastroenterology

Volumn 13, Issue 34, 2007, Pages 4554-4559

  Wu, Shu Kun ^a,c   Wang, Bao Ju ^a   Yang, Yan ^a   Feng, Xin Hua ^b   Zhao, Xi Ping ^a   Yang, Dong Liang ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c Hubei Provincial Corps Hospital   (China)

Author keywords

Hepatocellular carcinoma; Phosphorylated Smad2; PPM1A; PTEN

Indexed keywords

PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PHOSPHOPROTEIN PHOSPHATASE; PROTEIN PPM1A; SMAD2 PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER GRADING; CELL NUCLEUS; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; CYTOPLASM; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER; LIVER CARCINOGENESIS; LIVER CELL; LIVER CELL CARCINOMA; MALE; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

EID: 34648834791     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v13.i34.4554     Document Type: Article

References (13)

1. Sherman M. Hepatocellular carcinoma: epidemiology, risk factors, and screening. Semin Liver Dis 2005; 25: 143-154
2. Saffroy R, Pham P, Lemoine A, Debuire B. Molecular biology and hepatocellular carcinoma: current status and future prospects. Ann Biol Clin (Paris) 2004; 62: 649-656
3. Bissell DM. Chronic,liver injury, TGF-beta, and cancer. Exp Mol Med 2001; 33: 179-190
4. Hua YP, Huang JF, Liang LJ, Li SQ, Lai JM, Liang HZ. The study of inhibition effect of octreotide on the growth of hepatocellular carcinoma xenografts in situ in nude mice. Zhonghua Waike Zazhi 2005; 43: 721-725
5. Lin X, Duan X, Liang YY, Su Y, Wrigliton KH, Long J, Hu M, Davis CM, Wang J, Brurdcardi FC, Shi Y, Chen YG, Meng A, Feng XH. PPM1A functions as a Smad phosphatase to terminate TGFbeta signaling. Cell 2006; 125: 915-928
6. Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, Puc J, Miliaresis C, Rodgers L, McCombie R, Bigner SH, Giovanella BC, Ittmann M, Tycko B, Hibshoosh H, Wigler MH, Parsons R. PTEN, a putative protein tyrosine phosphatase gene mutated in human brani, breast, and prostate cancer. Science 1997; 275: 1943-1947
7. Myers MP, Stolarov JP, Eng C, Li J, Wang SI, Wigler MH, Parsons R, Tonks NK. P-TEN, the tumor suppressor from human chromosome 10q23, is a duaI-specificity phosphatase. Proc Natl Acad Sci USA 1997; 94: 9052-9057
8. Fujiwara Y, Hoon DS, Yamada T, Umeshita K, Gotoh M, Sakon M, Nishisho 1, Monden M. PTEN/MMAC1 mutation and frequent loss of heterozygosity identified in chromosome 10q in a subset of hepatocellular carcinomas. Jpn J Cancer Res 2000; 91: 287-292
9. Detre S, Saclani Jotti G, Dowsett M. A "quickscore" method for immunohistochemical semiquantitation: validation for oestrogen receptor in breast carcinomas. J Clin Pathol 1995; 48: 876-878
10. Steck PA, Pershouse MA, Jasser SA, Yung WK, Lin H, Ligon AH, Langford LA, Baumgard ML, Hattier T, Davis T, Frye C, Hu R, Swedlund B, Teng DH, Tavtigian SV. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet 1997; 15: 356-362
11. Yang Z, Yi J, Li X, Long W. Correlation between loss of PTEN expression and PKB/AKT phosphorylation in hepatocellular carcinoma. J Huazhong Univ Sci Technolog Med Sci 2005; 25: 45-47
12. Saadat M, Kikuchi K. Assignment of the gene encoding magnesium-dependent protein phosphatase lalpha (PPM1A) to human chromosome 14q22-->q23 and rat chromosome 6q24 by fluorescence in situ hybridization. Cytogenet Genome Res 2005; 108: 363
13. Xu L, Kang Y, Col S, Massague J. Smad2 nucleocytoplasmic shuttling by nucleoporins CAN/Nup214 and Nup153 feeds TGFbeta signaling complexes in the cytoplasm and nucleus. Mol Cell 2002; 10: 271-282